Opus Genetics Announces $1.7 Million in Project-Based Funding from Foundation to Fight Blindness to Support Two Preclinical Programs
Opus Genetics $1 million TRAP award to support preclinical safety study of gene therapy vector targeting rhodopsin-RHO-adRP Project and additional […]